226 related articles for article (PubMed ID: 20005148)
41. Intertwined regulation of angiogenesis and immunity by myeloid cells.
Rivera LB; Bergers G
Trends Immunol; 2015 Apr; 36(4):240-9. PubMed ID: 25770923
[TBL] [Abstract][Full Text] [Related]
42. The role of myeloid cells in the promotion of tumour angiogenesis.
Murdoch C; Muthana M; Coffelt SB; Lewis CE
Nat Rev Cancer; 2008 Aug; 8(8):618-31. PubMed ID: 18633355
[TBL] [Abstract][Full Text] [Related]
43. [Endothelial cell growth inhibitory gene].
Nakagami H; Kaneda T
Nihon Rinsho; 2006 Jul; 64 Suppl 5():428-31. PubMed ID: 16895210
[No Abstract] [Full Text] [Related]
44. Delineating Pro-Angiogenic Myeloid Cells in Cancer Therapy.
Johnson BW; Achyut BR; Fulzele S; Mondal AK; Kolhe R; Arbab AS
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30158456
[TBL] [Abstract][Full Text] [Related]
45. Influence of bone marrow-derived hematopoietic cells on the tumor response to radiotherapy: experimental models and clinical perspectives.
Ahn GO; Brown JM
Cell Cycle; 2009 Apr; 8(7):970-6. PubMed ID: 19270527
[TBL] [Abstract][Full Text] [Related]
46. Anti-cancer therapies targeting the tumor stroma.
Hofmeister V; Schrama D; Becker JC
Cancer Immunol Immunother; 2008 Jan; 57(1):1-17. PubMed ID: 17661033
[TBL] [Abstract][Full Text] [Related]
47. Targeting angiogenesis with monoclonal antibodies.
Bicknell R
Ann Oncol; 2006 Sep; 17 Suppl 10():x76-8. PubMed ID: 17018756
[No Abstract] [Full Text] [Related]
48. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.
Hanahan D; Folkman J
Cell; 1996 Aug; 86(3):353-64. PubMed ID: 8756718
[No Abstract] [Full Text] [Related]
49. VEGF-independent angiogenic pathways induced by PDGF-C.
Li X; Kumar A; Zhang F; Lee C; Li Y; Tang Z; Arjuna P
Oncotarget; 2010 Aug; 1(4):309-314. PubMed ID: 20871734
[TBL] [Abstract][Full Text] [Related]
50. VEGF in Signaling and Disease: Beyond Discovery and Development.
Apte RS; Chen DS; Ferrara N
Cell; 2019 Mar; 176(6):1248-1264. PubMed ID: 30849371
[TBL] [Abstract][Full Text] [Related]
51. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis.
Melincovici CS; Boşca AB; Şuşman S; Mărginean M; Mihu C; Istrate M; Moldovan IM; Roman AL; Mihu CM
Rom J Morphol Embryol; 2018; 59(2):455-467. PubMed ID: 30173249
[TBL] [Abstract][Full Text] [Related]
52. Screening and construction of nanobodies against human CD93 using phage libraries and study of their antiangiogenic effects.
Miao H; Wu Y; Ouyang H; Zhang P; Zheng W; Ma X
Front Bioeng Biotechnol; 2024; 12():1372245. PubMed ID: 38751868
[TBL] [Abstract][Full Text] [Related]
53. VEGF-induced Nrdp1 deficiency in vascular endothelial cells promotes cancer metastasis by degrading vascular basement membrane.
Li QQ; Guo M; He GH; Xi KH; Zhou MY; Shi RY; Chen GQ
Oncogene; 2024 Jun; 43(24):1836-1851. PubMed ID: 38654108
[TBL] [Abstract][Full Text] [Related]
54. Angiogenesis and Apoptosis: Data Comparison of Similar Microenvironments in the Corpus Luteum and Tumors.
Min T; Lee SH; Lee S
Animals (Basel); 2024 Apr; 14(7):. PubMed ID: 38612357
[TBL] [Abstract][Full Text] [Related]
55. Impact of Nintedanib and Anti-Angiogenic Agents on Uveal Melanoma Cell Behavior.
Pawlik VE; Sonntag SR; Grisanti S; Tura A; Kakkassery V; Ranjbar M
Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):30. PubMed ID: 38381412
[TBL] [Abstract][Full Text] [Related]
56. Mechanisms of tyrosine kinase inhibitor resistance in renal cell carcinoma.
Sweeney PL; Suri Y; Basu A; Koshkin VS; Desai A
Cancer Drug Resist; 2023; 6(4):858-873. PubMed ID: 38239394
[TBL] [Abstract][Full Text] [Related]
57. Vascular persistence following precision micropuncture.
Horchler SN; Hancock PC; Sun M; Liu AT; Massand S; El-Mallah JC; Goldenberg D; Waldron O; Landmesser ME; Agrawal S; Koduru SV; Ravnic DJ
Microcirculation; 2024 Jan; 31(1):e12835. PubMed ID: 37947797
[TBL] [Abstract][Full Text] [Related]
58. Angiogenesis and Lymphangiogenesis in Medulloblastoma Development.
Penco-Campillo M; Pages G; Martial S
Biology (Basel); 2023 Jul; 12(7):. PubMed ID: 37508458
[TBL] [Abstract][Full Text] [Related]
59. Vascular endothelial growth factor and risk of malignant brain tumor: A genetic correlation and two-sample Mendelian randomization study.
Zhang Q; Wu G; Zhang X; Zhang J; Jiang M; Zhang Y; Ding L; Wang Y
Front Oncol; 2023; 13():991825. PubMed ID: 36910644
[TBL] [Abstract][Full Text] [Related]
60. The VEGF/VEGFR Axis Revisited: Implications for Cancer Therapy.
Mabeta P; Steenkamp V
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
